Visualization of Src and FAK activity during the differentiation process from HMSCs to osteoblasts

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Liao, Xiaoling ^a,c   Lu, Shaoying ^b   Zhuo, Yue ^b   Winter, Christina ^b   Xu, Wenfeng ^a   Wang, Yingxiao ^b,c  

^a CHONGQING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b University of Illinois at Urbana Champaign   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; PROTEIN TYROSINE KINASE;

ARTICLE; CELL DIFFERENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOLECULAR IMAGING; OSTEOBLAST; SIGNAL TRANSDUCTION;

ALKALINE PHOSPHATASE; CELL DIFFERENTIATION; CELLS, CULTURED; ENZYME ACTIVATION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; KINETICS; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; OSTEOGENESIS; SPECTROPHOTOMETRY, ULTRAVIOLET; SRC-FAMILY KINASES;

EID: 84866635190     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042709     Document Type: Article

References (47)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. ((1999)) Multilineage potential of adult human mesenchymal stem cells. Science 284:: 143--147.
2. Porada CD, Almeida-Porada G, ((2010)) Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Adv Drug Deliv Rev 62:: 1156--1166.
3. Gersbach CA, Phillips JE, Garcia AJ, ((2007)) Genetic engineering for skeletal regenerative medicine. Annu Rev Biomed Eng 9:: 87--119.
4. Sheyn D, Mizrahi O, Benjamin S, Gazit Z, Pelled G, et al. ((2010)) Genetically modified cells in regenerative medicine and tissue engineering. Adv Drug Deliv Rev 62:: 683--698.
5. Sheyn D, Ruthemann M, Mizrahi O, Kallai I, Zilberman Y, et al. ((2010)) Genetically modified mesenchymal stem cells induce mechanically stable posterior spine fusion. Tissue Eng Part A 16:: 3679--3686.
6. Aicher WK, Buhring HJ, Hart M, Rolauffs B, Badke A, et al. ((2011)) Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells-potential and pitfalls. Adv Drug Deliv Rev 63:: 342--351.
7. Hench LL, Polak JM, ((2002)) Third-generation biomedical materials. Science 295:: 1014--1017.
8. Hench LL, Thompson I, ((2010)) Twenty-first century challenges for biomaterials. J R Soc Interface 7 Suppl 4: S379--391.
9. Tenney RM, Discher DE, ((2009)) Stem cells, microenvironment mechanics, and growth factor activation. Curr Opin Cell Biol 21:: 630--635.
10. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G, ((1997)) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:: 747--754.
11. Zambuzzi WF, Milani R, Teti A, ((2010)) Expanding the role of Src and protein-tyrosine phosphatases balance in modulating osteoblast metabolism: lessons from mice. Biochimie 92:: 327--332.
12. Discher DE, Mooney DJ, Zandstra PW, ((2009)) Growth factors, matrices, and forces combine and control stem cells. Science 324:: 1673--1677.
13. Satija NK, Gurudutta GU, Sharma S, Afrin F, Gupta P, et al. ((2007)) Mesenchymal stem cells: molecular targets for tissue engineering. Stem Cells Dev 16:: 7--23.
14. Muruganandan S, Roman AA, Sinal CJ, ((2009)) Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol Life Sci 66:: 236--253.
15. Lau E, Al-Dujaili S, Guenther A, Liu D, Wang L, et al. ((2010)) Effect of low-magnitude, high-frequency vibration on osteocytes in the regulation of osteoclasts. Bone 46:: 1508--1515.
16. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, et al. ((2002)) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:: 17--29.
17. Hamidouche Z, Hay E, Vaudin P, Charbord P, Schule R, et al. ((2008)) FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression. FASEB J 22:: 3813--3822.
18. Hong D, Chen HX, Xue Y, Li DM, Wan XC, et al. ((2009)) Osteoblastogenic effects of dexamethasone through upregulation of TAZ expression in rat mesenchymal stem cells. J Steroid Biochem Mol Biol 116:: 86--92.
19. Liu L, Yuan W, Wang J, ((2010)) Mechanisms for osteogenic differentiation of human mesenchymal stem cells induced by fluid shear stress. Biomech Model Mechanobiol 9:: 659--670.
20. Seong J, Ouyang M, Kim T, Sun J, Wen PC, et al. ((2011)) Detection of focal adhesion kinase activation at membrane microdomains by fluorescence resonance energy transfer. Nat Commun 2:: 406.
21. Mitra SK, Schlaepfer DD, ((2006)) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18:: 516--523.
22. Avizienyte E, Frame MC, ((2005)) Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr Opin Cell Biol 17:: 542--547.
23. Hakuno D, Takahashi T, Lammerding J, Lee RT, ((2005)) Focal adhesion kinase signaling regulates cardiogenesis of embryonic stem cells. J Biol Chem 280:: 39534--39544.
24. Brown MT, Cooper JA, ((1996)) Regulation, substrates and functions of src. Biochim Biophys Acta 1287:: 121--149.
25. Salasznyk RM, Klees RF, Williams WA, Boskey A, Plopper GE, ((2007)) Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells. Exp Cell Res 313:: 22--37.
26. Salasznyk RM, Klees RF, Boskey A, Plopper GE, ((2007)) Activation of FAK is necessary for the osteogenic differentiation of human mesenchymal stem cells on laminin-5. J Cell Biochem 100:: 499--514.
27. Koukouritaki SB, Gravanis A, Stournaras C, ((1999)) Tyrosine phosphorylation of focal adhesion kinase and paxillin regulates the signaling mechanism of the rapid nongenomic action of dexamethasone on actin cytoskeleton. Mol Med 5:: 731--742.
28. Marzia M, Sims NA, Voit S, Migliaccio S, Taranta A, et al. ((2000)) Decreased c-Src expression enhances osteoblast differentiation and bone formation. J Cell Biol 151:: 311--320.
29. Id Boufker H, Lagneaux L, Najar M, Piccart M, Ghanem G, et al. ((2010)) The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts. BMC Cancer 10:: 298.
30. Wang Y, Shyy JY, Chien S, ((2008)) Fluorescence proteins, live-cell imaging, and mechanobiology: seeing is believing. Annu Rev Biomed Eng 10:: 1--38.
31. Tsien RY, ((1998)) The green fluorescent protein. Annu Rev Biochem 67:: 509--544.
32. Wang Y, Botvinick EL, Zhao Y, Berns MW, Usami S, et al. ((2005)) Visualizing the mechanical activation of Src. Nature 434:: 1040--1045.
33. Ouyang M, Sun J, Chien S, Wang Y, ((2008)) Determination of hierarchical relationship of Src and Rac at subcellular locations with FRET biosensors. Proc Natl Acad Sci U S A 105:: 14353--14358.
34. Na S, Collin O, Chowdhury F, Tay B, Ouyang M, et al. ((2008)) Rapid signal transduction in living cells is a unique feature of mechanotransduction. Proc Natl Acad Sci U S A 105:: 6626--6631.
35. Wickham MQ, Erickson GR, Gimble JM, Vail TP, Guilak F (2003) Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin Orthop Relat Res: 196-212.
36. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, et al. ((2002)) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:: 4279--4295.
37. Gronthos S, Zannettino AC, Graves SE, Ohta S, Hay SJ, et al. ((1999)) Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. J Bone Miner Res 14:: 47--56.
38. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV, ((1994)) Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134:: 277--286.
39. Song Y, Madahar V, Liao J, ((2011)) Development of FRET assay into quantitative and high-throughput screening technology platforms for protein-protein interactions. Ann Biomed Eng 39:: 1224--1234.
40. Engler AJ, Sen S, Sweeney HL, Discher DE, ((2006)) Matrix elasticity directs stem cell lineage specification. Cell 126:: 677--689.
41. Kim TJ, Seong J, Ouyang M, Sun J, Lu S, et al. ((2009)) Substrate rigidity regulates Ca2+ oscillation via RhoA pathway in stem cells. J Cell Physiol 218:: 285--293.
42. Friedland JC, Lee MH, Boettiger D, ((2009)) Mechanically activated integrin switch controls alpha5beta1 function. Science 323:: 642--644.
43. Brunton VG, Frame MC, ((2008)) Src and focal adhesion kinase as therapeutic targets in cancer. Curr Opin Pharmacol 8:: 427--432.
44. Seong J, Lu S, Wang Y, ((2011)) Live Cell Imaging of Src/FAK Signaling by FRET. Cell Mol Bioeng 2:: 138--147.
45. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, et al. ((2004)) FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6:: 154--161.
46. Cary LA, Klinghoffer RA, Sachsenmaier C, Cooper JA, ((2002)) SRC catalytic but not scaffolding function is needed for integrin-regulated tyrosine phosphorylation, cell migration, and cell spreading. Mol Cell Biol 22:: 2427--2440.
47. Seong J, Lu S, Ouyang M, Huang H, Zhang J, et al. ((2009)) Visualization of Src activity at different compartments of the plasma membrane by FRET imaging. Chem Biol 16:: 48--57.